Spain, Lavinia
Larkin, James
Turajlic, Samra
Article History
Received: 4 November 2019
Revised: 9 December 2019
Accepted: 14 January 2020
First Online: 17 February 2020
Ethical approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: S.T. reports grants and speaker fees from Roche Tissue Diagnostics. J.L. reports institutional research support from BMS, MSD, Novartis, Pfizer, Achilles Therapeutics, Roche, Nektar Therapeutics, Covance, Immunocore, Pharmacyclics and Aveo, and consultancy support from Achilles, AZ, Boston Biomedical, BMS, Eisai, EUSA Pharma, GSK, Ipsen, Imugene, Incyte, iOnctura, Kymab, Merck Serono, MSD, Nektar, Novartis, Pierre Fabre, Pfizer, Roche/Genentech, Secarna and Vitaccess. L.S. has no conflicts of interest to declare.
: No funding was received in relation to this article.